Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
05/2000
05/04/2000WO2000024734A1 Lipoic acid derivatives and their use in treatment of disease
05/04/2000WO2000024724A1 Thiazole-derivatives
05/04/2000WO2000024718A1 Serine protease inhibitor
05/04/2000WO2000024717A2 Isoquinoline derivatives
05/04/2000WO2000024707A1 Substituted phenyl derivatives, their preparation and use
05/04/2000WO2000024437A2 Textured and porous silicone rubber
05/04/2000WO2000024426A1 Ribozymes used as prodrugs
05/04/2000WO2000024412A2 Use of vegf-c or vegf-d gene or protein to prevent restenosis
05/04/2000WO2000024405A1 Compounds and their therapeutic use with diabetic complications
05/04/2000WO2000024396A1 Treatment of disorders of the outer retina
05/04/2000WO2000024395A1 New use of glutamate antagonists for the treatment of cancer
05/04/2000WO2000024393A1 Combination product comprising an e-type prostaglandin ligand and a cox-2 selective inhibitor and methods of use
05/04/2000WO2000024391A2 Conductance of improperly folded proteins through the secretory pathway
05/04/2000WO2000024390A1 Method and composition for modulating amyloidosis
05/04/2000WO2000024383A1 Controlled-release pharmaceutical formulations containing a cgmp pde-5 inhibitor
05/04/2000WO2000024373A1 O/w emulsion comprising an hydroxylated oil
05/04/2000WO2000024365A1 Treatment of skin with adenosine or adenosine analog
05/04/2000WO2000024362A2 Δ9 tetrahydrocannabinol (δ9 thc) solution metered dose inhalers and methods of use
05/04/2000WO2000024261A1 Stromal cell use
05/04/2000WO2000012741A3 Inducible expression system
05/04/2000WO2000012139B1 Hypoxia regulated genes
05/04/2000WO2000007997A8 IMIDAZOLES AND RELATED COMPOUNDS AS α1A AGONISTS
05/04/2000WO2000006730A3 Human cytoskeletal proteins
05/04/2000WO2000006705A3 Genetically modified cd34-negative adherently growing stem cells and their use in gene therapy
05/04/2000WO2000006703A3 Inhibition of graft versus host disease
05/04/2000WO2000006254A3 Non-imidazole alkylamines as histamine h3-receptor ligands and their therapeutic applications
05/04/2000WO2000006187A3 Modulation of apoptosis
05/04/2000WO2000004910A3 Low molecular weight components of shark cartilage, processes for their preparation and therapeutic uses thereof
05/04/2000WO2000004868A3 Libraries of polyhydroxamates and their analogs
05/04/2000WO2000004862A3 Bioenhanced formulations comprising eprosartan in oral solid dosage form
05/04/2000WO2000002917A3 Compounds and methods for modulating cadherin-mediated functions
05/04/2000WO2000002544A3 Use of piperine for treating skin pigmentation disorders
05/04/2000WO1999067283A8 Two-kinase domain mitogen- and stress-activated protein kinases and uses thereof
05/04/2000WO1999066959A3 Compositions and methods for delivery of genetic material for altering neuronal growth, regeneration, and survival
05/04/2000WO1999064038A9 Novel analgesic agents
05/04/2000WO1999064031A9 β2-ADRENERGIC RECEPTOR AGONISTS
05/04/2000WO1999063988A9 Inhibitors of nitric oxide synthase
05/04/2000WO1999062315A3 Method for altering the activity of proteins of the pka signaling pathway
05/04/2000WO1999054286A3 Btk inhibitors and methods for their identification and use
05/04/2000WO1999043672A9 Inhibitors of phospholipase a2
05/04/2000DE19850363A1 Polymere für kosmetische Formulierungen Polymers for cosmetic formulations
05/04/2000DE19850131A1 Chromenon- und Chromanonderivate Chromenon- and chromanone
05/04/2000DE19850072A1 Phosphinat-Peptidanaloga zur Behandlung von fibrotischen Erkrankungen Phosphinate-peptide analogues in the treatment of fibrotic diseases
05/04/2000CA2349211A1 Prv-1 gene and the use thereof
05/04/2000CA2348844A1 Compounds and their therapeutic use with diabetic complications
05/04/2000CA2348833A1 Human phospholipases
05/04/2000CA2348770A1 Stromal cell use
05/04/2000CA2348529A1 Conductance of improperly folded proteins through the secretory pathway
05/04/2000CA2348430A1 Ovary-specific genes and proteins
05/04/2000CA2348165A1 Dihydropyridine compounds and methods of use
05/04/2000CA2348046A1 Lysine-rich statherin protein
05/04/2000CA2348019A1 Method and composition for modulating amyloidosis
05/04/2000CA2347993A1 Method for producing in vivo proteins chemically diversified by incorporating non-standard amino acids
05/04/2000CA2347983A1 Inhibition of transglutaminase-mediated microbial infection of a mammalian host
05/04/2000CA2347911A1 Single morphic forms of known peptide metalloproteinase inhibitors
05/04/2000CA2347365A1 Combination product comprising an e-type prostaglandin ligand and a cox-2 selective inhibitor and methods of use
05/04/2000CA2347293A1 Nucleic acids encoding osteoprotegerin-like proteins and methods of using same
05/04/2000CA2347032A1 O/w emulsion comprising an hydroxylated oil
05/04/2000CA2346990A1 Serine protease inhibitor
05/04/2000CA2344637A1 .delta.9 tetrahydrocannabinol (.delta.9 thc) solution metered dose inhalers and methods of use
05/04/2000CA2342626A1 Substituted phenyl derivatives, their preparation and use
05/04/2000CA2249648A1 Mammalian subtilisin/kexin isozyme ski-1: a proprotein convertase with a unique cleavage specificity
05/03/2000EP0997466A1 Novel antimicrobial lactam-quinolones
05/03/2000EP0997464A1 1,3,8-Triazaspiro[4,5] decanone compounds as orl1-receptor agonists
05/03/2000EP0997460A1 Benzothiophene compounds as antithrombotic agents and intermediates
05/03/2000EP0997459A1 Intermediates for preparing retroviral protease inhibiting compounds
05/03/2000EP0997457A1 3-benzoylindole derivatives and drugs containing the same
05/03/2000EP0997145A1 Methods for identifying compounds for inhibition of neoplastic lesions, and pharmaceutical compositions containing such compounds
05/03/2000EP0996858A2 Interactions of atm, atr or dna-pk with p53
05/03/2000EP0996728A2 IMPROVED ANTI-IgE ANTIBODIES AND METHOD OF IMPROVING POLYPEPTIDES
05/03/2000EP0996723A1 Human phosphatidylinositol transfer protein gamma
05/03/2000EP0996721A2 Secreted proteins and polynucleotides encoding them
05/03/2000EP0996716A1 Zggbp1,novel peptides related to bipolar affective disorder type 1, sequences and uses thereof
05/03/2000EP0996710A1 Component of bromelain
05/03/2000EP0996709A1 INHIBITORS OF CELLULOLYTIC, XYLANOLYTIC AND $g(b)-GLUCANOLYTIC ENZYMES
05/03/2000EP0996632A1 Angiostatin fragments and method of use
05/03/2000EP0996622A1 Novel spiroazabicyclic heterocyclic compounds
05/03/2000EP0996621A1 Novel compounds
05/03/2000EP0996620A1 Novel compounds
05/03/2000EP0996619A1 Tropane analogs and methods for inhibition of monoamine transport
05/03/2000EP0996618A1 Endothelin antagonists: n- 2'- (4,5-dimethyl-3-isoxazolyl) amino]sulfonyl]-4-(2-oxazolyl) 1,1'-biphenyl]-2-yl]methyl] -n,3,3-trimethylbutanamide and n-(4,5-dimethyl-3-isoxazolyl) -2'- (3,3-dimethyl-2-oxo-1-pyrrolidinyl) methyl] -4'-(2-oxazolyl) 1,1'-biphenyl]-2-sulfonamide and salts thereof
05/03/2000EP0996617A1 Novel compounds
05/03/2000EP0996612A2 Aliphatic propargylamines as cellular rescue agents
05/03/2000EP0996466A2 Novel composition comprising an ssri and a beta-blocker
05/03/2000EP0996465A1 Compositions and articles for reducing the effects of inflammation
05/03/2000EP0996463A2 Catalytic monoclonal antibodies with protease activity for the selective lysis of the protein component of plaques and aggregates related to pathological conditions
05/03/2000EP0996454A1 Polyallylamine polymers for treating hypercholesterolemia
05/03/2000EP0996451A1 Triterpene saponin analogs having adjuvant and immunostimulatory activity
05/03/2000EP0996446A1 Novel substituted imidazole compounds
05/03/2000EP0996444A1 Treatment of diabetes with thiazolidinedione and metformin
05/03/2000EP0996443A1 Certain diarylimidazole derivatives; a new class of npy specific ligands
05/03/2000EP0996440A1 Method for treatment of glutamate related disorders
05/03/2000EP0996435A1 Amino acid derivatives useful to treat stroke
05/03/2000EP0996433A1 Methods for treatment of conditions associated with lactosylceramide
05/03/2000EP0996431A1 Synergistic compositions of lycopene and vitamin e for the prevention of ldl oxidation
05/03/2000EP0754043B1 Inhibition of smooth muscle cell migration by (r)-amlodipine
05/03/2000EP0721465B1 Glutathione s-transferase-activated compounds
05/03/2000EP0719767B1 Succinamic acid compound, process for producing the same, and use thereof
05/03/2000EP0691985B1 Phosphonomethyldipeptides
05/03/2000EP0652768B1 A pharmaceutical preparation for the synergistic activation of natural killer cells
1 ... 1161 1162 1163 1164 1165 1166 1167 1168 1169 1170 1171 1172 1173 1174 1175 1176 1177 1178 1179 1180 1181 ... 1564